RS BioTherapeutics Enters Into License Agreement With Synthonics for First Investigational Compound
https://www.yahoo.com/now/rs-biotherapeutics-enters-license-agreement-150000478.html
EXTENDED ABSORPTION OF LIOTHYRONINE FROM POLY-ZINC-LIOTHYRONINE (PZL) IN HUMANS
https://www.medrxiv.org/content/10.1101/2021.06.14.21258437v1.full.pdf
Phase 1 Clinical Trial of Poly-Zinc-Liothyronine Demonstrates Slow-Release Serum T3 Kinetics
https://www.liebertpub.com/doi/epub/10.1089/ct.2022%3B34.9-12
Controlled Release of Liothyronine (LT3) Shown in First Clinical Trial of PolyZincLiothyronine (PZL)
https://www.biospace.com/article/controlled-release-of-liothyronine-lt3-shown-in-first-clinical-trial-of-polyzincliothyronine-pzl-/
Synthonics to Begin Clinical Trial of Extended Release T3
https://www.biospace.com/article/synthonics-to-begin-clinical-trial-of-extended-release-t3/
Sustained Release T3 Therapy: Animal Models and Translational Applications
https://www.frontiersin.org/articles/10.3389/fendo.2019.00544/full